Views & Analysis What will the digital health ecosystem look like post-COVID? COVID-19 has turned the world on its head and healthcare systems have had to respond rapidly to match the sudden changes created by lockdown.
Views & Analysis New survey reveals patients’ changing opinions of pharma Exclusive research from WEGO Health has revealed patients’ changing attitudes towards the pharma industry and how they want to see companies improve.
Views & Analysis AstraZeneca on expanding its diabetes research franchise AstraZeneca is hoping to build a strong focus on cardiovascular, renal, and metabolic (CVRM) diseases.
Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
News Daiichi and AZ pull Dato-DXd filing in Europe too AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.